financetom
Business
financetom
/
Business
/
Nike CEO Change a 'Positive' Catalyst for Shares, Deutsche Bank Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nike CEO Change a 'Positive' Catalyst for Shares, Deutsche Bank Says
Sep 22, 2024 9:18 AM

09:08 AM EDT, 09/20/2024 (MT Newswires) -- Nike's ( NKE ) upcoming leadership transition is a "positive" catalyst for its shares as it is expected to increase the company's return to sustained growth, Deutsche Bank said in a note to clients.

Late Thursday, Nike ( NKE ) said Elliott Hill will rejoin the company as chief executive officer, starting Oct. 14, succeeding John Donahoe, who will retire from the role Oct. 13.

"We believe this highly anticipated leadership change will inject a much-needed sense of urgency, focusing on product innovation, storytelling/marketing, and rebuilding wholesale partnerships - areas that suffered under previous leadership resulting in material underperformance in profitability and shareholder returns," Deutsche Bank said.

The bank said Hill has "strong" internal and retail partner relationships that should immediately boost morale.

Deutsche Bank has a buy rating on Nike ( NKE ), with a price target of $92.

Nike ( NKE ) shares were up 8.4% in premarket activity on Friday.

Price: 87.78, Change: +6.80, Percent Change: +8.40

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell
Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell
Mar 17, 2025
09:05 AM EDT, 03/17/2025 (MT Newswires) -- Vtv Therapeutics ( VTVT ) said Monday that the US Food and Drug Administration has lifted a clinical hold on its cadisegliatin clinical program, including a phase 3 trial in type 1 diabetes. The company said it plans to resume the trial after submitting a protocol amendment to reduce its duration from 12...
IceCure Gets Notice of Allowance from China's Intellectual Property Regulator
IceCure Gets Notice of Allowance from China's Intellectual Property Regulator
Mar 17, 2025
09:06 AM EDT, 03/17/2025 (MT Newswires) -- IceCure Medical ( ICCM ) said Monday that it has received a notice of allowance from the China National Intellectual Property Administration for its cryogenic system connector invention. The notice follows grants for the same patent in the US, Europe, and Japan, the company said. The company said its novel cryogenic pump is...
Robinhood launches prediction markets to tap into event contracts demand
Robinhood launches prediction markets to tap into event contracts demand
Mar 17, 2025
(Reuters) -Trading platform Robinhood on Monday launched a prediction markets hub in its app that allows customers to trade on event outcomes, including the expected upper limit of the Federal Reserve funds rate in May. The company, which has become synonymous with retail investors in the U.S., is looking to cash in on the growing demand for event-based derivative contracts,...
Market Chatter: HSBC Said to Discuss Sale of $8.3 Billion of Australian Home Loans
Market Chatter: HSBC Said to Discuss Sale of $8.3 Billion of Australian Home Loans
Mar 17, 2025
09:02 AM EDT, 03/17/2025 (MT Newswires) -- HSBC Holdings ( HSBC ) is in talks to sell about A$13 billion ($8.3 billion) of Australian home loans, Bloomberg reported Monday, citing people familiar with the matter. HSBC ( HSBC ) did not immediately reply to a request for comment from MT Newswires. (Market Chatter news is derived from conversations with market...
Copyright 2023-2025 - www.financetom.com All Rights Reserved